Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BHMT | Q93088 | 1/20 | 0.38 |
| ▸ | GABRP | O00591 | 2/20 | 0.37 |
| ▸ | GABRD | O14764 | 2/20 | 0.37 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.37 |
| ▸ | GABRB1 | P18505 | 2/20 | 0.37 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.37 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.37 |
| ▸ | GABRA5 | P31644 | 2/20 | 0.37 |
| ▸ | GABRA3 | P34903 | 2/20 | 0.37 |
| ▸ | GABRA2 | P47869 | 2/20 | 0.37 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.37 |
| ▸ | GABRA4 | P48169 | 2/20 | 0.37 |
| ▸ | GABRE | P78334 | 2/20 | 0.37 |
| ▸ | GABRA6 | Q16445 | 2/20 | 0.37 |
| ▸ | GABRG1 | Q8N1C3 | 2/20 | 0.37 |
| ▸ | GABRG3 | Q99928 | 2/20 | 0.37 |
| ▸ | GABRQ | Q9UN88 | 2/20 | 0.37 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.37 |
| ▸ | CACNA2D1 | P54289 | 2/20 | 0.36 |
| ▸ | CACNB3 | P54284 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16240143 | 1.00 | BHMT (0.38) | BHMTGABRPGABRDGABRA1GABRB1 | |
| SCHEMBL16240224 | 0.82 | BHMT (0.35) | BHMTGABRPGABRDGABRA1GABRB1 | |
| SCHEMBL16240225 | 0.82 | BHMT (0.35) | BHMTGABRPGABRDGABRA1GABRB1 | |
| SCHEMBL16240652 | 0.79 | DPP4 (0.54) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL16240651 | 0.79 | DPP4 (0.54) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL24964979 | 0.77 | DPP4 (0.39) | BHMTGABRPGABRDGABRA1GABRB1 | |
| SCHEMBL10349046 | 0.77 | DPP4 (0.39) | BHMTGABRPGABRDGABRA1GABRB1 | |
| SCHEMBL16171989 | 0.77 | SLC1A3 (0.35) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL31676717 | 0.77 | SLC22A6 (0.39) | BHMTGABRR1DPP4GRIK1GRIA2 | |
| Hydrochloric Acid SCHEMBL10925209 | 0.76 | ALDH1A1 (0.33) | SLC7A5SLC1A3SLC1A2SLC1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2813558-B1 | GELLING AGENT | AJINOMOTO KK (JP) | 2018-01-17 | — | — | EP | disclosed |
| US-9522104-B2 | Gelling agent | AJINOMOTO CO., INC. (JP) | 2016-12-20 | — | — | US | disclosed |
| EP-2813558-A1 | GELLING AGENT | Ajinomoto Co., Inc. (JP) | 2014-12-17 | — | — | EP | disclosed |
| US-20140341960-A1 | GELLING AGENT | AJINOMOTO CO., INC. (JP) | 2014-11-20 | — | — | US | disclosed |
| CN-104105772-A | Gelling agent | AJINOMOTO KK | 2014-10-15 | — | — | CN | disclosed |
| EP-0406623-B1 | Polyaspartic acid derivatives as a coating for pharmaceutical forms and foodstuffs | ROEHM GMBH (DE) | 1994-11-30 | — | — | EP | disclosed |
| US-5175285-A | POLYMERS DERIVED FROM POLYSUCCINIMIDE, USED AS SURFACE COATINGS FOR MEDICINALS AND FOODS | ROHM GMBH CHEMISCHE FABRIK (DE) | 1992-12-29 | — | — | US | disclosed |
| EP-0406623-A2 | Polyaspartic acid derivatives as a coating for pharmaceutical forms and foodstuffs | Röhm GmbH (DE) | 1991-01-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140341960-A1 | GELLING AGENT | CUTA, DEK, SUCLG1 | BHMT 3584/4885GABRP 759/4885GABRD 430/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.